Episode
Episode 62 of The Living Life Well Show: FDA Ban on Desiccated Thyroid Medications: Armour Thyroid, NP Thyroid, and Nature-Throid Explained
- Podcast
- The Living Life Well Show
- Published
- Aug 17, 2025
- Duration seconds
- 1328
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-living-life-well-show-6657027/episodes/episode-62-of-the-living-life-well-show-fda-ban-on-desiccated-thyroid-medications-armour-thyroid-np-thyroid-and-nature-throid-explained/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-living-life-well-show-6657027/episode-62-of-the-living-life-well-show-fda-ban-on-desiccated-thyroid-medications-armour-thyroid-np-thyroid-and-nature-throid-explained.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The Living Life Well Show – Episode 62 Title: FDA Ban on Desiccated Thyroid Medications: Armour Thyroid, NP Thyroid, and Nature-Throid Explained Host: Dr. Jon Skelton Episode Summary: In this episode, Dr. Jon Skelton discusses the recent FDA ban on desiccated thyroid medications, specifically Armour Thyroid, NP Thyroid, and Nature-Throid. He explains what these medications are, why the FDA has taken action, and what this means for patients and practitioners. Dr. Skelton also explores alternative treatment options and offers practical advice for those affected by the ban. Key Topics Covered: Introduction to the Living Life Well Show and Dr. Skelton’s approach: integrating faith, science, and common sense for healthy living. Overview of the FDA’s recent ban on animal-derived (desiccated) thyroid medications. Explanation of what desiccated thyroid medications are and how they differ from synthetic thyroid hormones. The FDA’s reasoning: lack of biologic certification, quality control concerns, and reported adverse events. Historical context: the use of desiccated thyroid since the 1950s and the shift to synthetic T4 (levothyroxine). The challenges and nuances of dosing with both desiccated and synthetic thyroid medications. Who is affected: over 1.5 million Americans currently use these medications. Clinical perspective: why some patients need both T4 and T3, and the limitations of current synthetic-only options. The impact of the ban on patients, including insurance and compounding pharmacy challenges. Practical advice for patients: Don’t panic or stockpile medications. Talk to your doctor about optimizing T4 to T3 conversion. Consider nutritional support (iodine, selenium, zinc, vitamin D, vitamin A). Stay informed and advocate for your needs. Dr. Skelton’s outlook: hope…